GSK buys bacteria vaccine firm
February 11, 2015Research and Development, Sales and Marketing EC, GSK, GlaxoSmithKline, GlycoVaxyn, Novartis, vaccines
GlaxoSmithKline is continuing the significant expansion of its vaccine business with the purchase of Swiss biopharma company GlycoVaxyn. The UK …
MRC Technology hires senior head from Shire
February 11, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Edward Bliss, MRC, Shire
UK medical research charity MRC Technology has appointed Dr Edward Bliss to the new role of general counsel and company …
Pharma’s reputation ‘is worsening among patients’
February 10, 2015Medical Communications, Research and Development, Sales and Marketing HIV, ViiV Healthcare, patientview, pharma, reputation, transparency
Only around four in ten patients believe pharma has a good reputation and many companies are failing to win patient …
Charity challenges Sovaldi patent
February 10, 2015Sales and Marketing Gilead, HCV, Médecins du Monde, sofosbuvir, sovaldi, world health organization
Doctors of the World (also known as Médecins du Monde) has filed an opposition to the patent for Gilead’s blockbuster …
Gilead expands UK presence with new London HQ
February 10, 2015Research and Development, Sales and Marketing Cambridge, Gilead, London, NICE, UK, johnson, medcity, sovaldi, uxbridge
Gilead is to create a new UK commercial secondary headquarters in central London doubling its UK workforce to 600 by …
Second late-stage COPD trial for GSK and Theravance
February 10, 2015Sales and Marketing COPD, FF/UMEC/VI, GSK, Theravance, fluticasone furoate, umeclidinium, vilanterol
GlaxoSmithKline and Theravance have begun a second Phase III trial of their investigational triple combination COPD drug as the former …
Hospira recalls Propofol drug again
February 10, 2015Manufacturing and Production, Sales and Marketing Hospira, Pfizer, diprivan, manufacturing, merger, propofol
Hospira has issued a recall of anaesthesia support drug Propofol after the neck of one vial was revealed to contain …
Pfizer replaces UK managing director
February 10, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Erik Nordkamp, Pfizer, jonathan emms
Erik Nordkamp has been named as the managing director of Pfizer UK to take over from Jonathan Emms. Emms has …
MHRA shuts down unlicensed cancer drug facility
February 9, 2015Manufacturing and Production, Sales and Marketing Cambridge, GcMAF, MHRA, first immune, globulin component macrophage activating factor
The MHRA has shut down an unlicensed Cambridgeshire plant that was producing a potentially dangerous drug to be sold online. …
New president for ABPI
February 9, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Amgen, Pfizer, Whitehead, emms, john kearney
The Association of the British Pharmaceutical Industry has appointed John Kearney as its new president. Stepping into the role in …
FDA clears Roche eye drug
February 9, 2015Sales and Marketing AMD, DME, FDA, Lucentis, Retina, Roche, eyes, ranibizumab
The US Food and Drug Administration has shown Roche’s eye-condition drug Lucentis the green light to treat patients with diabetic …
Financial round-up: how has pharma fared in 2014?
February 9, 2015Medical Communications, Research and Development, Sales and Marketing
A select look at the latest figures and performance from some of the industry’s big players:MerckQuarter four 2014 sales Sales of …
Centogene appoints chief business officer
February 9, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Péter Adorján, centogene
Dr Péter Adorján has been appointed to the board of German rare disease firm Centogene and thereby extending its board …
Changing our minds about depression
February 9, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Campbell, Lamb, Lundbeck, depression, economist, mind
Alastair Campbell, former Labour spin doctor and depression patient, thinks that mental and physical health should not be seen as …
Sanofi sales lifted by diabetes and rare diseases
February 6, 2015Sales and Marketing Genzyme, Lantus, Sanofi, diabetes, financials, insulin glargine, praluent, q4
Sanofi racked up €7.4 billion in sales in the fourth quarter of 2014 according to the company’s latest financials report. …
NHS reform was ‘distracting and damaging’
February 6, 2015Sales and Marketing CDF, Cameron, NHS, UK, coalition, healthcare, king's fund
Healthcare think tank The King’s Fund has said through a report that organisational changes to the NHS under the coalition …
AstraZeneca looks for revenue boost via Actavis buy
February 6, 2015Sales and Marketing Actavis, AstraZeneca, Brilinta, Forxiga, diabetes, fourth quarter, q4
AstraZeneca recorded a dip in revenue in the last quarter of 2014 and is looking to ramp up its respiratory …
Flu vaccine ineffective against this season’s strain
February 6, 2015Research and Development, Sales and Marketing A(H3N2, Public Health England, UK, Vaccine, WHO, flu, phe
This season’s flu vaccine has provided little protection against the main strain circulating in the UK according to a new …
US hospitals trial Apple’s HealthKit
February 6, 2015Medical Communications, Sales and Marketing Apple, Health Mate, Motion 24/7 Sleeptracker, Samsung, google, healthkit, wearables
A pilot programme for Apple’s mobile health platform HealthKit has been rolled out across a number of US hospitals to …
Martindale Pharma appoints sales director
February 6, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing eric vick, martindale pharma
UK speciality pharma firm Martindale Pharma has appointed Eric Vick to be its group director of international sales. Eric has …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
